Header cover image

Investing Ideas
/
Hong Kong Pharmaceuticals & Biotech High Insider Buying

Hong Kong Pharmaceuticals & Biotech High Insider Buying

Results

10

0 new

Stocks with high levels of insider buying the past 3 months and good analyst coverage.

10 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	1177 Sino Biopharmaceutical	HK$2.83	6.0%	-17.3%	HK$51.9b	HK$4.59	PE26.1x	E13.7%	1.8%
	512 Grand Pharmaceutical Group	HK$4.75	2.2%	10.0%	HK$16.6b	n/a	PE8.8x	E13.9%	5.5%
	867 China Medical System Holdings	HK$6.70	1.2%	-43.5%	HK$16.3b	HK$10.84	PE6.3x	E6.8%	6.3%
	6660 AIM Vaccine	HK$6.84	-2.6%	-84.4%	HK$8.3b	HK$52.97	PS6.5x	S56.4%	n/a
	2171 CARsgen Therapeutics Holdings	HK$4.38	-8.8%	-56.8%	HK$2.5b	HK$7.20	PB1.3x	E20.4%	n/a
	3737 Zhongzhi Pharmaceutical Holdings	HK$1.25	0%	5.0%	HK$1.1b	n/a	PE6.2x	n/a	4.8%
	1652 Fusen Pharmaceutical	HK$1.05	8.2%	-18.6%	HK$776.3m	n/a	PS1.3x	n/a	0%
	950 Lee's Pharmaceutical Holdings	HK$1.13	-6.6%	-17.5%	HK$665.4m	HK$1.00	PE39.8x	S16.1%	1.6%
	6628 Transcenta Holding	HK$1.51	-0.7%	-68.2%	HK$611.0m	HK$8.69	PS10.6x	E10.0%	n/a
	1889 Sanai Health Industry Group	HK$0.017	-15.0%	-76.4%	HK$65.0m	n/a	PE3.2x	n/a	0%

Page 1 of 1